Literature DB >> 2377170

[Effect of a bovine surfactant in very low birth weight premature infants with congenital pneumonia].

L Gortner1, F Pohlandt, P Bartmann.   

Abstract

15 VLBW-infants, who were classified to suffer from congenital pneumonia, were treated with a bovine surfactant. Mean gestational age was 25.5 weeks (range 23-27 weeks), mean birth weight was 700 g (range 530-930 g). Surfactant was instilled intratracheally at a mean dose of 41 mg/kg body weight (b.w.) (range 30-50 mg) 8 h after birth (range 6-12 h), if the fraction of inspired oxygen (FiO2) was greater than 0.5 or the peak inspiratory pressure (PIP) was greater than 22 cm H2O (b.w. less than 750 g) or greater than 25 cm H2O (b.w. 751-1000 g). Retreatment up to a total maximum of 4 doses of surfactant was permitted. Surfactant treatment reduced FiO2 from a pretreatment value of 0.79 to 0.50 one hour after application, however, 12 h later FiO2 had increased again to 0.75. Ventilation pressures showed a slight decrease during 12 h after surfactant treatment. 6 infants received 1 dose, multiple doses were given to 9 infants. 5 infants survived, 4 infants died from respiratory failure, 4 from sepsis and 2 from severe intracranial haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2377170

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd        ISSN: 0026-9298            Impact factor:   0.323


  3 in total

1.  Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.

Authors:  A van't Veen; J W Mouton; D Gommers; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.

Authors:  Maddalena Facco; Matteo Nespeca; Manuela Simonato; Ilena Isak; Giovanna Verlato; Gianluca Ciambra; Chiara Giorgetti; Virgilio P Carnielli; Paola E Cogo
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

3.  Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease--research or clinical application?

Authors:  A Greenough
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.